PDS Biotechnology PDSB
NASDAQ PDSB
$1.02 -0.01 (-0.97%)
At close: Nov 11, 2026 · 4:00 PM EST

PDS Biotechnology (PDSB) Long-Term Deferred Tax (2020 - 2024)

Updated

Analysis

PDS Biotechnology (PDSB) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PDS Biotechnology 57.60 Mn -22.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 46,623.00
Dec 31, 2023 56,817.00
Dec 31, 2022 148,290.00
Dec 31, 2021 100,523.00
Dec 31, 2020 153,960.00
API Access

PDS Biotechnology Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PDSB&period=max&api_key=YOUR_API_KEY